Lewis-Wambi, Joan S

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis. [electronic resource] - Breast cancer research : BCR 2008 - R104 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

1465-542X

10.1186/bcr2208 doi


Animals
Annexin A5--metabolism
Antimetabolites, Antineoplastic--pharmacology
Apoptosis--drug effects
Blotting, Western
Breast Neoplasms--drug therapy
Buthionine Sulfoximine--pharmacology
Cell Proliferation--drug effects
Cytochromes c--metabolism
Drug Resistance, Neoplasm
Drug Synergism
Estradiol--pharmacology
Estrogens--deficiency
Female
Forkhead Transcription Factors--physiology
Glutathione--metabolism
Humans
Immunoenzyme Techniques
In Situ Nick-End Labeling
JNK Mitogen-Activated Protein Kinases--metabolism
Membrane Potential, Mitochondrial--drug effects
Mice
Mice, Nude
Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors
RNA, Messenger--genetics
RNA, Small Interfering--pharmacology
Reverse Transcriptase Polymerase Chain Reaction
Tumor Cells, Cultured
bcl-2-Associated X Protein--metabolism